Laura C Coates, Christopher T Ritchlin, Laure Gossec, Philip S Helliwell, Proton Rahman, Alexa P Kollmeier, Xie L Xu, May Shawi, Chetan S Karyekar, Christine Contré, Wim Noël, Shihong Sheng, Yanli Wang, Stephen Xu, Philip J Mease. Rheumatology (Oxford) 2022
Times Cited: 1
Times Cited: 1
List of co-cited articles
articles co-cited >1
Times Cited
Times Co-cited
Similarity
Comparative effectiveness of guselkumab in psoriatic arthritis: results from systematic literature review and network meta-analysis.
Philip J Mease, Iain B McInnes, Lai-Shan Tam, Kiefer Eaton, Steve Peterson, Agata Schubert, Soumya D Chakravarty, Anna Parackal, Chetan S Karyekar, Sandhya Nair,[...]. Rheumatology (Oxford) 2021
Philip J Mease, Iain B McInnes, Lai-Shan Tam, Kiefer Eaton, Steve Peterson, Agata Schubert, Soumya D Chakravarty, Anna Parackal, Chetan S Karyekar, Sandhya Nair,[...]. Rheumatology (Oxford) 2021
100
A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index.
A Calin, S Garrett, H Whitelock, L G Kennedy, J O'Hea, P Mallorie, T Jenkinson. J Rheumatol 1994
A Calin, S Garrett, H Whitelock, L G Kennedy, J O'Hea, P Mallorie, T Jenkinson. J Rheumatol 1994
100
Classification criteria for psoriatic arthritis: development of new criteria from a large international study.
William Taylor, Dafna Gladman, Philip Helliwell, Antonio Marchesoni, Philip Mease, Herman Mielants. Arthritis Rheum 2006
William Taylor, Dafna Gladman, Philip Helliwell, Antonio Marchesoni, Philip Mease, Herman Mielants. Arthritis Rheum 2006
100
Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis.
C Lukas, R Landewé, J Sieper, M Dougados, J Davis, J Braun, S van der Linden, D van der Heijde. Ann Rheum Dis 2009
C Lukas, R Landewé, J Sieper, M Dougados, J Davis, J Braun, S van der Linden, D van der Heijde. Ann Rheum Dis 2009
100
Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria.
S van der Linden, H A Valkenburg, A Cats. Arthritis Rheum 1984
S van der Linden, H A Valkenburg, A Cats. Arthritis Rheum 1984
100
Axial involvement in psoriatic arthritis: An update for rheumatologists.
Denis Poddubnyy, Deepak R Jadon, Filip Van den Bosch, Philip J Mease, Dafna D Gladman. Semin Arthritis Rheum 2021
Denis Poddubnyy, Deepak R Jadon, Filip Van den Bosch, Philip J Mease, Dafna D Gladman. Semin Arthritis Rheum 2021
100
Guselkumab in biologic-naive patients with active psoriatic arthritis (DISCOVER-2): a double-blind, randomised, placebo-controlled phase 3 trial.
Philip J Mease, Proton Rahman, Alice B Gottlieb, Alexa P Kollmeier, Elizabeth C Hsia, Xie L Xu, Shihong Sheng, Prasheen Agarwal, Bei Zhou, Yanli Zhuang,[...]. Lancet 2020
Philip J Mease, Proton Rahman, Alice B Gottlieb, Alexa P Kollmeier, Elizabeth C Hsia, Xie L Xu, Shihong Sheng, Prasheen Agarwal, Bei Zhou, Yanli Zhuang,[...]. Lancet 2020
100
Endorsement of definitions of disease activity states and improvement scores for the Ankylosing Spondylitis Disease Activity Score: results from OMERACT 10.
Pedro M M C Machado, Robert B M Landewé, Désirée M van der Heijde. J Rheumatol 2011
Pedro M M C Machado, Robert B M Landewé, Désirée M van der Heijde. J Rheumatol 2011
100
A Systematic Review With Network Meta-Analysis of the Available Biologic Therapies for Psoriatic Disease Domains.
Tiago Torres, Anabela Barcelos, Paulo Filipe, João Eurico Fonseca. Front Med (Lausanne) 2021
Tiago Torres, Anabela Barcelos, Paulo Filipe, João Eurico Fonseca. Front Med (Lausanne) 2021
100
Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 Treatment Recommendations for Psoriatic Arthritis.
Laura C Coates, Arthur Kavanaugh, Philip J Mease, Enrique R Soriano, Maria Laura Acosta-Felquer, April W Armstrong, Wilson Bautista-Molano, Wolf-Henning Boehncke, Willemina Campbell, Alberto Cauli,[...]. Arthritis Rheumatol 2016
Laura C Coates, Arthur Kavanaugh, Philip J Mease, Enrique R Soriano, Maria Laura Acosta-Felquer, April W Armstrong, Wilson Bautista-Molano, Wolf-Henning Boehncke, Willemina Campbell, Alberto Cauli,[...]. Arthritis Rheumatol 2016
100
Real-life efficacy of guselkumab in patients with early psoriatic arthritis.
Ilenia Pantano, Daniele Mauro, Francesca Romano, Alessio Gambardella, Mario Valenti, Davide Simone, Daniela Iacono, Antonio Costanzo, Giuseppe Argenziano, Francesco Ciccia. Rheumatology (Oxford) 2022
Ilenia Pantano, Daniele Mauro, Francesca Romano, Alessio Gambardella, Mario Valenti, Davide Simone, Daniela Iacono, Antonio Costanzo, Giuseppe Argenziano, Francesco Ciccia. Rheumatology (Oxford) 2022
100
A multi-item Physician Global Assessment scale to assess psoriasis disease severity: validation based on four phase III tofacitinib studies.
Kristina Callis Duffin, Andrew G Bushmakin, Joseph C Cappelleri, Lotus Mallbris, Carla Mamolo. BMC Dermatol 2019
Kristina Callis Duffin, Andrew G Bushmakin, Joseph C Cappelleri, Lotus Mallbris, Carla Mamolo. BMC Dermatol 2019
100
Guselkumab, an inhibitor of the IL-23p19 subunit, provides sustained improvement in signs and symptoms of active psoriatic arthritis: 1 year results of a phase III randomised study of patients who were biologic-naïve or TNFα inhibitor-experienced.
Christopher T Ritchlin, Philip S Helliwell, Wolf-Henning Boehncke, Enrique R Soriano, Elizabeth C Hsia, Alexa P Kollmeier, Soumya D Chakravarty, Federico Zazzetti, Ramanand A Subramanian, Xie L Xu,[...]. RMD Open 2021
Christopher T Ritchlin, Philip S Helliwell, Wolf-Henning Boehncke, Enrique R Soriano, Elizabeth C Hsia, Alexa P Kollmeier, Soumya D Chakravarty, Federico Zazzetti, Ramanand A Subramanian, Xie L Xu,[...]. RMD Open 2021
100
Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): updated treatment recommendations for psoriatic arthritis 2021.
Laura C Coates, Enrique R Soriano, Nadia Corp, Heidi Bertheussen, Kristina Callis Duffin, Cristiano B Campanholo, Jeffrey Chau, Lihi Eder, Daniel G Fernández-Ávila, Oliver FitzGerald,[...]. Nat Rev Rheumatol 2022
Laura C Coates, Enrique R Soriano, Nadia Corp, Heidi Bertheussen, Kristina Callis Duffin, Cristiano B Campanholo, Jeffrey Chau, Lihi Eder, Daniel G Fernández-Ávila, Oliver FitzGerald,[...]. Nat Rev Rheumatol 2022
100
Special Article: 2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis.
Jasvinder A Singh, Gordon Guyatt, Alexis Ogdie, Dafna D Gladman, Chad Deal, Atul Deodhar, Maureen Dubreuil, Jonathan Dunham, M Elaine Husni, Sarah Kenny,[...]. Arthritis Rheumatol 2019
Jasvinder A Singh, Gordon Guyatt, Alexis Ogdie, Dafna D Gladman, Chad Deal, Atul Deodhar, Maureen Dubreuil, Jonathan Dunham, M Elaine Husni, Sarah Kenny,[...]. Arthritis Rheumatol 2019
100
Influence of Axial Involvement on Clinical Characteristics of Psoriatic Arthritis: Analysis from the Corrona Psoriatic Arthritis/Spondyloarthritis Registry.
Philip J Mease, Jacqueline B Palmer, Mei Liu, Arthur Kavanaugh, Renganayaki Pandurengan, Christopher T Ritchlin, Chitra Karki, Jeffrey D Greenberg. J Rheumatol 2018
Philip J Mease, Jacqueline B Palmer, Mei Liu, Arthur Kavanaugh, Renganayaki Pandurengan, Christopher T Ritchlin, Chitra Karki, Jeffrey D Greenberg. J Rheumatol 2018
100
Comparison of remission and low disease activity states with DAPSA, MDA and VLDA in a clinical trial setting in psoriatic arthritis patients: 2-year results from the FUTURE 2 study.
Laura C Coates, Peter Nash, Tore K Kvien, Laure Gossec, Philip J Mease, Lawrence Rasouliyan, Luminita Pricop, Steffen M Jugl, Kunal K Gandhi, Corine Gaillez,[...]. Semin Arthritis Rheum 2020
Laura C Coates, Peter Nash, Tore K Kvien, Laure Gossec, Philip J Mease, Lawrence Rasouliyan, Luminita Pricop, Steffen M Jugl, Kunal K Gandhi, Corine Gaillez,[...]. Semin Arthritis Rheum 2020
100
Guselkumab in patients with active psoriatic arthritis who were biologic-naive or had previously received TNFα inhibitor treatment (DISCOVER-1): a double-blind, randomised, placebo-controlled phase 3 trial.
Atul Deodhar, Philip S Helliwell, Wolf-Henning Boehncke, Alexa P Kollmeier, Elizabeth C Hsia, Ramanand A Subramanian, Xie L Xu, Shihong Sheng, Prasheen Agarwal, Bei Zhou,[...]. Lancet 2020
Atul Deodhar, Philip S Helliwell, Wolf-Henning Boehncke, Alexa P Kollmeier, Elizabeth C Hsia, Ramanand A Subramanian, Xie L Xu, Shihong Sheng, Prasheen Agarwal, Bei Zhou,[...]. Lancet 2020
100
A multidimensional health assessment questionnaire (MDHAQ) for all patients with rheumatic diseases to complete at all visits in standard clinical care.
Theodore Pincus. Bull NYU Hosp Jt Dis 2007
Theodore Pincus. Bull NYU Hosp Jt Dis 2007
100
Secukinumab provides sustained PASDAS-defined remission in psoriatic arthritis and improves health-related quality of life in patients achieving remission: 2-year results from the phase III FUTURE 2 study.
L C Coates, D D Gladman, P Nash, O FitzGerald, A Kavanaugh, T K Kvien, L Gossec, V Strand, L Rasouliyan, L Pricop,[...]. Arthritis Res Ther 2018
L C Coates, D D Gladman, P Nash, O FitzGerald, A Kavanaugh, T K Kvien, L Gossec, V Strand, L Rasouliyan, L Pricop,[...]. Arthritis Res Ther 2018
100
Assessment of the many faces of PsA: single and composite measures in PsA clinical trials.
Dylan McGagh, Laura C Coates. Rheumatology (Oxford) 2020
Dylan McGagh, Laura C Coates. Rheumatology (Oxford) 2020
100
The ASAS Health Index (ASAS HI) - a new tool to assess the health status of patients with spondyloarthritis.
U Kiltz, D van der Heijde, A Boonen, J Braun. Clin Exp Rheumatol 2014
U Kiltz, D van der Heijde, A Boonen, J Braun. Clin Exp Rheumatol 2014
100
100
EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update.
Laure Gossec, Xenofon Baraliakos, Andreas Kerschbaumer, Maarten de Wit, Iain McInnes, Maxime Dougados, Jette Primdahl, Dennis G McGonagle, Daniel Aletaha, Andra Balanescu,[...]. Ann Rheum Dis 2020
Laure Gossec, Xenofon Baraliakos, Andreas Kerschbaumer, Maarten de Wit, Iain McInnes, Maxime Dougados, Jette Primdahl, Dennis G McGonagle, Daniel Aletaha, Andra Balanescu,[...]. Ann Rheum Dis 2020
100
The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection.
M Rudwaleit, D van der Heijde, R Landewé, J Listing, N Akkoc, J Brandt, J Braun, C T Chou, E Collantes-Estevez, M Dougados,[...]. Ann Rheum Dis 2009
M Rudwaleit, D van der Heijde, R Landewé, J Listing, N Akkoc, J Brandt, J Braun, C T Chou, E Collantes-Estevez, M Dougados,[...]. Ann Rheum Dis 2009
100
Patient's Global Assessment as an Outcome Measure for Psoriatic Arthritis in Clinical Practice: A Surrogate for Measuring Low Disease Activity?
Ennio Lubrano, Fabio Massimo Perrotta, Wendy J Parsons, Antonio Marchesoni. J Rheumatol 2015
Ennio Lubrano, Fabio Massimo Perrotta, Wendy J Parsons, Antonio Marchesoni. J Rheumatol 2015
100
Efficacy and safety of guselkumab in biologic-naïve patients with active axial psoriatic arthritis: study protocol for STAR, a phase 4, randomized, double-blinded, placebo-controlled trial.
Dafna D Gladman, Philip J Mease, Paul Bird, Enrique R Soriano, Soumya D Chakravarty, May Shawi, Stephen Xu, Sean T Quinn, Cinty Gong, Evan Leibowitz,[...]. Trials 2022
Dafna D Gladman, Philip J Mease, Paul Bird, Enrique R Soriano, Soumya D Chakravarty, May Shawi, Stephen Xu, Sean T Quinn, Cinty Gong, Evan Leibowitz,[...]. Trials 2022
100
Efficacy and Safety of Guselkumab, an Interleukin-23p19-Specific Monoclonal Antibody, Through One Year in Biologic-Naive Patients With Psoriatic Arthritis.
Iain B McInnes, Proton Rahman, Alice B Gottlieb, Elizabeth C Hsia, Alexa P Kollmeier, Soumya D Chakravarty, Xie L Xu, Ramanand A Subramanian, Prasheen Agarwal, Shihong Sheng,[...]. Arthritis Rheumatol 2021
Iain B McInnes, Proton Rahman, Alice B Gottlieb, Elizabeth C Hsia, Alexa P Kollmeier, Soumya D Chakravarty, Xie L Xu, Ramanand A Subramanian, Prasheen Agarwal, Shihong Sheng,[...]. Arthritis Rheumatol 2021
100
RAPID3 (Routine Assessment of Patient Index Data) on an MDHAQ (Multidimensional Health Assessment Questionnaire): agreement with DAS28 (Disease Activity Score) and CDAI (Clinical Disease Activity Index) activity categories, scored in five versus more than ninety seconds.
Theodore Pincus, Christopher J Swearingen, Martin J Bergman, C Lee Colglazier, Alan T Kaell, Arthur M Kunath, Evan L Siegel, Yusuf Yazici. Arthritis Care Res (Hoboken) 2010
Theodore Pincus, Christopher J Swearingen, Martin J Bergman, C Lee Colglazier, Alan T Kaell, Arthur M Kunath, Evan L Siegel, Yusuf Yazici. Arthritis Care Res (Hoboken) 2010
100
Treatment guidelines in psoriatic arthritis.
Alexis Ogdie, Laura C Coates, Dafna D Gladman. Rheumatology (Oxford) 2020
Alexis Ogdie, Laura C Coates, Dafna D Gladman. Rheumatology (Oxford) 2020
100
Efficacy and safety of guselkumab in patients with active psoriatic arthritis who are inadequate responders to tumour necrosis factor inhibitors: results through one year of a phase IIIb, randomised, controlled study (COSMOS).
Laura C Coates, Laure Gossec, Elke Theander, Paul Bergmans, Marlies Neuhold, Chetan S Karyekar, May Shawi, Wim Noël, Georg Schett, Iain B McInnes. Ann Rheum Dis 2022
Laura C Coates, Laure Gossec, Elke Theander, Paul Bergmans, Marlies Neuhold, Chetan S Karyekar, May Shawi, Wim Noël, Georg Schett, Iain B McInnes. Ann Rheum Dis 2022
100
Determining the Minimally Important Difference in the Clinical Disease Activity Index for Improvement and Worsening in Early Rheumatoid Arthritis Patients.
J R Curtis, S Yang, L Chen, J E Pope, E C Keystone, B Haraoui, G Boire, J C Thorne, D Tin, C A Hitchon,[...]. Arthritis Care Res (Hoboken) 2015
J R Curtis, S Yang, L Chen, J E Pope, E C Keystone, B Haraoui, G Boire, J C Thorne, D Tin, C A Hitchon,[...]. Arthritis Care Res (Hoboken) 2015
100
Development of a health index in patients with ankylosing spondylitis (ASAS HI): final result of a global initiative based on the ICF guided by ASAS.
U Kiltz, D van der Heijde, A Boonen, A Cieza, G Stucki, M A Khan, W P Maksymowych, H Marzo-Ortega, J Reveille, S Stebbings,[...]. Ann Rheum Dis 2015
U Kiltz, D van der Heijde, A Boonen, A Cieza, G Stucki, M A Khan, W P Maksymowych, H Marzo-Ortega, J Reveille, S Stebbings,[...]. Ann Rheum Dis 2015
100
Defining minimal disease activity in psoriatic arthritis: a proposed objective target for treatment.
L C Coates, J Fransen, P S Helliwell. Ann Rheum Dis 2010
L C Coates, J Fransen, P S Helliwell. Ann Rheum Dis 2010
100
Development and validation of the Spondyloarthritis Research Consortium of Canada (SPARCC) Enthesitis Index.
W P Maksymowych, C Mallon, S Morrow, K Shojania, W P Olszynski, R L Wong, J Sampalis, B Conner-Spady. Ann Rheum Dis 2009
W P Maksymowych, C Mallon, S Morrow, K Shojania, W P Olszynski, R L Wong, J Sampalis, B Conner-Spady. Ann Rheum Dis 2009
100
100
Long-Term Efficacy and Safety of Guselkumab, a Monoclonal Antibody Specific to the p19 Subunit of Interleukin-23, Through Two Years: Results From a Phase III, Randomized, Double-Blind, Placebo-Controlled Study Conducted in Biologic-Naive Patients With Active Psoriatic Arthritis.
Iain B McInnes, Proton Rahman, Alice B Gottlieb, Elizabeth C Hsia, Alexa P Kollmeier, Xie L Xu, Yusang Jiang, Shihong Sheng, May Shawi, Soumya D Chakravarty,[...]. Arthritis Rheumatol 2022
Iain B McInnes, Proton Rahman, Alice B Gottlieb, Elizabeth C Hsia, Alexa P Kollmeier, Xie L Xu, Yusang Jiang, Shihong Sheng, May Shawi, Soumya D Chakravarty,[...]. Arthritis Rheumatol 2022
100
Disease activity and response assessment in psoriatic arthritis using the Disease Activity index for PSoriatic Arthritis (DAPSA). A brief review.
Josef S Smolen, Monika Schoels, Daniel Aletaha. Clin Exp Rheumatol 2015
Josef S Smolen, Monika Schoels, Daniel Aletaha. Clin Exp Rheumatol 2015
100
Patient global assessment in psoriatic arthritis: a multicenter GRAPPA and OMERACT study.
Alberto Cauli, Dafna D Gladman, Alessandro Mathieu, Ignazio Olivieri, Giovanni Porru, Paul P Tak, Claudia Sardu, Ilona Ujfalussy, Raffaele Scarpa, Antonio Marchesoni,[...]. J Rheumatol 2011
Alberto Cauli, Dafna D Gladman, Alessandro Mathieu, Ignazio Olivieri, Giovanni Porru, Paul P Tak, Claudia Sardu, Ilona Ujfalussy, Raffaele Scarpa, Antonio Marchesoni,[...]. J Rheumatol 2011
100
Disease activity in psoriatic arthritis (PsA): defining remission and treatment success using the DAPSA score.
Monika M Schoels, Daniel Aletaha, Farideh Alasti, Josef S Smolen. Ann Rheum Dis 2016
Monika M Schoels, Daniel Aletaha, Farideh Alasti, Josef S Smolen. Ann Rheum Dis 2016
100
Physician's Global Assessment in Psoriatic Arthritis: A Multicenter GRAPPA Study.
Alberto Cauli, Dafna D Gladman, Alessandro Mathieu, Ignazio Olivieri, Giovanni Porru, Paul P Tak, Claudia Sardu, Raffaele Scarpa, Antonio Marchesoni, William J Taylor,[...]. J Rheumatol 2018
Alberto Cauli, Dafna D Gladman, Alessandro Mathieu, Ignazio Olivieri, Giovanni Porru, Paul P Tak, Claudia Sardu, Raffaele Scarpa, Antonio Marchesoni, William J Taylor,[...]. J Rheumatol 2018
100
GRAPPA Treatment Recommendations: Updates and Methods.
Arthur Kavanaugh, Laura C Coates, Danielle A van der Windt, Nadia Corp, Enrique R Soriano. J Rheumatol Suppl 2020
Arthur Kavanaugh, Laura C Coates, Danielle A van der Windt, Nadia Corp, Enrique R Soriano. J Rheumatol Suppl 2020
100
Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 2. Psoriatic arthritis: overview and guidelines of care for treatment with an emphasis on the biologics.
Alice Gottlieb, Neil J Korman, Kenneth B Gordon, Steven R Feldman, Mark Lebwohl, John Y M Koo, Abby S Van Voorhees, Craig A Elmets, Craig L Leonardi, Karl R Beutner,[...]. J Am Acad Dermatol 2008
Alice Gottlieb, Neil J Korman, Kenneth B Gordon, Steven R Feldman, Mark Lebwohl, John Y M Koo, Abby S Van Voorhees, Craig A Elmets, Craig L Leonardi, Karl R Beutner,[...]. J Am Acad Dermatol 2008
100
A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index.
S Garrett, T Jenkinson, L G Kennedy, H Whitelock, P Gaisford, A Calin. J Rheumatol 1994
S Garrett, T Jenkinson, L G Kennedy, H Whitelock, P Gaisford, A Calin. J Rheumatol 1994
100
Guselkumab: the First Selective IL-23 Inhibitor for Active Psoriatic Arthritis in Adults.
Wolf-Henning Boehncke, Nicolo Costantino Brembilla, Michael John Nissen. Expert Rev Clin Immunol 2021
Wolf-Henning Boehncke, Nicolo Costantino Brembilla, Michael John Nissen. Expert Rev Clin Immunol 2021
100
Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.